Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://journals.lww.com/cardiovascularpharm/abstract/2020/11000/the_glitazars_paradox__cardiotoxicity_of_the.4.aspx, but it redirected us to https://journals.lww.com/cardiovascularpharm/abstract/2020/11000/the_glitazars_paradox__cardiotoxicity_of_the.4.aspx. The analysis below is for the second page.

Title[redir]:
Journal of Cardiovascular Pharmacology
Description:
oliferator-activated receptor (PPAR) alpha and PPARγ are used for the treatment of hyperlipidemia and hyperglycemia, respectively. PPARs belong to the nuclear receptors superfamily and regulate fatty acid metabolism. PPARα ligands, such as fibrates, reduce circulating triglyceride levels, and PPARγ agonists, such as thiazolidinediones, improve insulin sensitivity. Dual-PPARα/γ agonists (glitazars) were developed to combine the beneficial effects of PPARα and PPARγ agonism. Although they improved metabolic parameters, they paradoxically aggravated congestive heart failure in patients with type-2 diabetes via mechanisms that remain elusive. Many of the glitazars, such as muraglitazar, tesaglitazar, and aleglitazar, were abandoned in phase-III clinical trials. The objective of this review article pertains to the understanding of how combined PPARα and PPARγ activation, which successfully targets the major complications of diabetes, causes cardiac dysfunction. Furthermore, it aims to suggest interventions that will maintain the beneficial effects of dual PPARα/γ agonism and alleviate adverse cardiac outcomes in diabetes....

Matching Content Categories {📚}

  • Health & Fitness
  • Games
  • Video & Online Content

Content Management System {📝}

What CMS is doi.org built with?


Doi.org uses MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

journal, pparγ, diabetes, issue, pparα, access, subscribe, alerts, authors, abstract, article, glitazars, beneficial, complications, agonists, log, register, articles, issues, review, dual, activation, cardiovascular, buy, patients, type, hyperglycemia, hyperlipidemia, major, treatment, effects, agonism, cardiac, copyright, wolters, kluwer, health, rights, reserved, text, subscribers, request, browse, content, submit, service, privacy, policy, logo, advanced,

Topics {✒️}

peroxisome proliferator-activated receptor phase-iii clinical trials dual pparα/γ agonism dual-pparα/γ agonists journal authors submit full text access nuclear receptors superfamily improve insulin sensitivity improved metabolic parameters artificial intelligence training major therapeutic approach review article pertains etoc alerts service request 800-638-3030 register subscribe individual subscribers log 0000000000000891 buy abstract journal tables issue pparγ agonism cardiac dysfunction website subscribe pparα ligands combined pparα journal beneficial effects pparγ activation major complications center submit pparγ agonists charikleia md cardiovascular pharmacology 76 common complications cardiovascular disease complications constitutes ppars belong remain elusive successfully targets suggest interventions rights reserved email inbox data mining type-2 diabetes diabetes mellitus konstantinos ms glitazars paradox authors content pparα agonists

Questions {❓}

  • Not a Subscriber?

Social Networks {👍}(1)

External Links {🔗}(58)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

4.53s.